Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Lung Cancer

Free Subscription 25.01.2010 2 Am J Respir Cell Mol Biol 1 Ann Surg Oncol 1 Arch Pathol Lab Med 1 BMJ 5 Cancer 1 Cancer Chemother Pharmacol 1 Cancer Lett 6 Clin Lung Cancer 1 Epidemiology 1 Eur Respir J 1 Int J Cancer 2 J Clin Oncol 3 J Thorac Oncol 4 Lung Cancer 1 Oncologist 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Am J Respir Cell Mol Biol

1. LI MY , Yuan H, Ma LT, Kong AW, et al
   Roles of PPAR{alpha} and PPAR{gamma} in the Development of Non-small Cell Lung Cancer.
   Am J Respir Cell Mol Biol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
2. ROMAN J , Ritzenthaler JD, Roser-Page S, Sun X, et al
   {alpha}5{beta}1 Integrin Expression is Essential for Tumor Progression in Experimental Lung Cancer.
   Am J Respir Cell Mol Biol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   

   
   Ann Surg Oncol

3. HUO A
   In Reply: Radiofrequency Ablation (RFA) of Pulmonary Metastases: Technical Success vs. Actual Benefit.
   Ann Surg Oncol. 2010.
   PubMed     Text format     Related articles   
   
   

   
   Arch Pathol Lab Med

4. CHIRIEAC LR , Flieder DB
   High-resolution computed tomography screening for lung cancer: unexpected findings and new controversies regarding adenocarcinogenesis.
   Arch Pathol Lab Med. 2010;134:41-8.
   PubMed     Text format     Related articles    Abstract available
   
   

   
   BMJ

5. RAINE R , Wong W, Scholes S, Ashton C, et al
   Social variations in access to hospital care for patients with colorectal, breast, and lung cancer between 1999 and 2006: retrospective analysis of hospital episode statistics.
   BMJ. 2010;340:b5479.
   PubMed     Text format     Related articles    Abstract available
   
   

   
   Cancer

6. BONOMI PD
   Implications of key trials in advanced nonsmall cell lung cancer.
   Cancer. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
7. CREMONA M , Calabro E, Randi G, De Bortoli M, et al
   Elevated levels of the acute-phase serum amyloid are associated with heightened lung cancer risk.
   Cancer. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
8. RAMALINGAM SS , Foster J, Gooding W, Evans T, et al
   Phase 2 study of irinotecan and paclitaxel in patients with recurrent or refractory small cell lung cancer.
   Cancer. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
9. SCHREIBER D , Rineer J, Weedon J, Vongtama D, et al
   Survival outcomes with the use of surgery in limited-stage small cell lung cancer: should its role be re-evaluated?
   Cancer. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
10. PALLIS AG , Shepherd FA, Lacombe D, Gridelli C, et al
    Treatment of small-cell lung cancer in elderly patients.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    

    
    Cancer Chemother Pharmacol

11. KWON JH , Kim JH, Lee JA, Shin HC, et al
    Phase II study with fractionated schedule of docetaxel and cisplatin in patients with advanced non-small cell lung cancer.
    Cancer Chemother Pharmacol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    

    
    Cancer Lett

12. LI C , Schuetz JD, Naren AP
    Tobacco carcinogen NNK transporter MRP2 regulates CFTR function in lung epithelia: Implications for lung cancer.
    Cancer Lett. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    

    
    Clin Lung Cancer

13. MANSON GV , Ma PC
    Response to pemetrexed chemotherapy in lung adenocarcinoma-bronchioloalveolar carcinoma insensitive to erlotinib.
    Clin Lung Cancer. 2010;11:57-60.
    PubMed     Text format     Related articles    Abstract available
    
    
14. KUO CH , Lin SM, Lee KY, Chung FT, et al
    Subsequent chemotherapy improves survival outcome in advanced non-small-cell lung cancer with acquired tyrosine kinase inhibitor resistance.
    Clin Lung Cancer. 2010;11:51-6.
    PubMed     Text format     Related articles    Abstract available
    
    
15. HUBER RM , Borgmeier A, Flentje M, Willner J, et al
    Concurrent chemoradiation therapy with docetaxel/cisplatin followed by docetaxel consolidation therapy in inoperable stage IIIA/B non-small-cell lung cancer: results of a phase I study.
    Clin Lung Cancer. 2010;11:45-50.
    PubMed     Text format     Related articles    Abstract available
    
    
16. KUMAR S , Guleria R, Singh V, Bharti AC, et al
    Plasma nucleosome levels might predict response to therapy in patients with advanced non-small-cell lung cancer.
    Clin Lung Cancer. 2010;11:36-44.
    PubMed     Text format     Related articles    Abstract available
    
    
17. RAEZ LE , Kobina S, Santos ES
    Oxaliplatin in first-line therapy for advanced non-small-cell lung cancer.
    Clin Lung Cancer. 2010;11:18-24.
    PubMed     Text format     Related articles    Abstract available
    
    
18. GOVINDAN R
    A review of epidermal growth factor receptor/HER2 inhibitors in the treatment of patients with non-small-cell lung cancer.
    Clin Lung Cancer. 2010;11:8-12.
    PubMed     Text format     Related articles    Abstract available
    
    

    
    Epidemiology

19. RICHARDSON DB
    Occupational Exposures and Lung Cancer: Adjustment for Unmeasured Confounding by Smoking.
    Epidemiology. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    

    
    Eur Respir J

20. STRAND TE , Rostad H, Wentzel-Larsen T, von Plessen C, et al
    A population-based evaluation of the seventh edition of the TNM system for lung cancer.
    Eur Respir J. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    

    
    Int J Cancer

21. TIMOFEEVA M , Kropp S, Sauter W, Beckmann L, et al
    Genetic polymorphisms of MPO, GSTT1, GSTM1, GSTP1, EPHX1 and NQO1 as risk factors of early-onset lung cancer.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    

    
    J Clin Oncol

22. DAHLBERG SE , Sandler AB, Brahmer JR, Schiller JH, et al
    Clinical Course of Advanced Non-Small-Cell Lung Cancer Patients Experiencing Hypertension During Treatment With Bevacizumab in Combination With Carboplatin and Paclitaxel on ECOG 4599.
    J Clin Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
23. BLASBERG JD , Pass HI, Goparaju CM, Flores RM, et al
    Reduction of Elevated Plasma Osteopontin Levels With Resection of Non-Small-Cell Lung Cancer.
    J Clin Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    

    
    J Thorac Oncol

24. CHIAPPORI A , Bepler G, Barlesi F, Soria JC, et al
    Phase II, Double-Blinded, Randomized Study of Enzastaurin Plus Pemetrexed as Second-Line Therapy in Patients with Advanced Non-small Cell Lung Cancer.
    J Thorac Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
25. KOH Y , Jang B, Han SW, Kim TM, et al
    Expression of Class III Beta-Tubulin Correlates with Unfavorable Survival Outcome in Patients with Resected Non-small Cell Lung Cancer.
    J Thorac Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
26. MILLER AA , Pang H, Hodgson L, Ramnath N, et al
    A Phase II Study of Dasatinib in Patients with Chemosensitive Relapsed Small Cell Lung Cancer (Cancer and Leukemia Group B 30602).
    J Thorac Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    

    
    Lung Cancer

27. MIOTTO D , Cascio NL, Stendardo M, Querzoli P, et al
    CD8+ T cells expressing IL-10 are associated with a favourable prognosis in lung cancer.
    Lung Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
28. JACOB S , Hovey E, Ng W, Vinod S, et al
    Estimation of an optimal chemotherapy utilisation rate for lung cancer: An evidence-based benchmark for cancer care.
    Lung Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
29. BAYMAN N , Alam N, Faivre-Finn C
    Radiotherapy for lung cancer in the elderly.
    Lung Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
30. GAZDAR AF , Gao B, Minna JD
    Lung cancer cell lines: Useless artifacts or invaluable tools for medical science?
    Lung Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    

    
    Oncologist

31. NEAL JW
    Histology Matters: Individualizing Treatment in Non-Small Cell Lung Cancer.
    Oncologist. 2010.
    PubMed     Text format     Related articles   
    
    

    
    Proc Natl Acad Sci U S A

32. PINE SR , Ryan BM, Varticovski L, Robles AI, et al
    Microenvironmental modulation of asymmetric cell division in human lung cancer cells.
    Proc Natl Acad Sci U S A. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: